CClinicalTrials.gg
CompletedNCT02264561Updated Apr 8, 2015

Caffeine's Effect on Attention

An interventional study of Food and Food in Attention, sponsored by Société des Produits Nestlé (SPN). Completed at 1 site in Netherlands. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-08.

Sponsored by Société des Produits Nestlé (SPN) · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
71
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether caffeine improves attention.

Read the detailed description

Single centre single dose cross-over, placebo-controlled, double blind, randomized trial with two treatment conditions : caffeine and placebo

02

Conditions studied

  • Attention
03

In context

Lead sponsor

Société des Produits Nestlé (SPN) is the lead sponsor of 314 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Healthy male and female Aged 40-60 years

05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
71 participants (actual)

Study arms

  • Placebo comparator
    Placebo

    Mannitol administered at visit 1 and at visit 2

    Other: Food

  • Active comparator
    caffeine

    caffeine administered at visit 1 and at visit 2

    Other: Food

Interventions

  • OtherFood

    Active group

    Also known as: Caffeine

  • OtherFood

    Control group

    Also known as: Placebo

06

What researchers measure

Primary outcomes

  1. Attention test: milliseconds and index of stimulus sensitivity

    Time frame: duration 10 days from screening to last visit (V2)

Secondary outcomes

  1. Central Nervous System :response time.

    Time frame: duration: 10 days from screening to last visit (V2)

  2. Mood measures: Visual Analog scale.

    Time frame: duration 10 days from screening to last visit V2

07

Study locations

1 site
  • Center for Human Drug Research
    Leiden, CL 2333, Netherlands
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02264561
Lead sponsor
Société des Produits Nestlé (SPN)
Responsible party
Sponsor
First posted
Oct 15, 2014
Start date
Sep 2014
Primary completion
Dec 2014
Completion
Dec 2014
Last update
Apr 8, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion